BioPharmSignal logoBioPharmSignal

Biotech News

Flyte Aviation Expands International Operations to Canada

Catheter Precision (VTAK)Catheter PrecisionFDA / regulatory

Flyte Aviation, Inc. (NYSE American: VJET) (“Flyte” or the “Company”), a technology-enabled private aviation company, today announced that it has received approval from Transport Canada , the department of the Canadian Government overseeing air travel, to commence flights in and out of Canada, extending its geographic reach into a new North American market.

Related news

VTAKCatheter Precision2026-11-02 13:00 EST

Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population

VTAKCatheter Precision2026-09-28 10:00 EST

Flyte Named Official Air Travel Partner of the 34th Annual Hamptons International Film Festival

HYPRHyperfine2026-11-03 21:05 EST

Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences

DNLIDenali Therapeutics2026-10-30 13:30 EST

Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product

JNJJohnson & Johnson2026-10-23 11:09 EST

European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapse

ICUSeaStar Medical2026-11-03 13:21 EST

FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients

JNJJohnson & Johnson2026-10-16 10:31 EST

CHMP recommends approval of Johnson & Johnson’s TALVEY®▼ (talquetamab) plus daratumumab in earlier line treatment of relapsed/refractory multiple myeloma

ICUSeaStar Medical2026-10-07 12:16 EST

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

ICCMIceCure Medical2026-09-10 11:58 EST

IceCure Medical Receives Regulatory Approval to Market ProSense® in China

ACHCAcadia Healthcare2026-09-25 20:05 EST

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

View all latest news

Catheter Precision

Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments. VIVO Cardiac Mapping System VIVO is a non-invasive three-dimensional mapping system used...

Recent company news

VTAKCatheter Precision2026-11-02 13:00 EST

Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population

VTAKCatheter Precision2026-10-29 20:15 EST

Flyte Aviation Expands International Operations to Canada

VTAKCatheter Precision2026-10-22 20:54 EST

Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device

VTAKCatheter Precision2026-10-20 20:20 EST

Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner Portal

VTAKCatheter Precision2026-10-14 12:00 EST

Flyte Aviation Partners with The Philadelphia 76ers

Stock data

Close
1.51 USD
Market cap
2.58M USD
Exchange
NYSE
Sector
MedTech
Location
United States